ONO PHARMA USA is the US subsidiary of ONO PHARMACEUTICAL CO, LTD., an R&D-oriented pharmaceutical company founded in 1717 with headquarters in Osaka, Japan. For over 300 years, ONO has been committed to delivering novel medicines to patients with high unmet medical need. Our passion has led to first-in-class therapies including the world’s first chemically synthesized prostaglandins as well as nivolumab, the world’s first anti-PD-1 antibody. These drugs have changed the treatment paradigm and outlook for millions of people globally.
Today, ONO has a growing pipeline of innovative therapeutics across four focus areas: Oncology, immunology, neurology, and specialty medicine. ONO is committed to Challenging the Unknown, relentlessly pursuing research that will bring safe and effective solutions to more patients around the world.
Community Guidelines: https://www.ono-usa.com/sites/default/files/media_document/linkedIn_community_guidelines.pdf
|
|
|
51-200 employees
View all ONO PHARMA USA, INC. employees
|
|
Pharmaceuticals
|
|
$10M–$50M
|
|
(609) 514-2000
|
|
1 Main Street, Suite 1050, Cambridge, Massachusetts 02142, US
|
|
None
|
ONO PHARMA USA, INC. headquarters is located at 1 Main Street, Suite 1050, Cambridge, Massachusetts 02142, US.
ONO PHARMA USA, INC. generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact ONO PHARMA USA, INC. by calling (609) 514-2000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.